By InvitationNot Applicable

Robot-Assisted Immersive Escape Room Game for Tobacco Harm Prevention Among Elementary School Students

Taiwan200 participantsStarted 2026-04-01

Plain-language summary

This study evaluates the effectiveness of a robot-assisted immersive escape room intervention for tobacco harm prevention among upper-grade elementary school students. A total of 200 fifth- and sixth-grade students from elementary schools in New Taipei City, Taiwan, will participate in this quasi-experimental, parallel-group design. Participants will be allocated non-randomly to either the experimental group, which receives the robot-assisted immersive escape room intervention, or the active comparator group, which receives standard classroom-based tobacco harm prevention education. In the experimental arm, an educational robot named "Anti-Smoking Kebbi" serves as a non-player character (NPC) to facilitate human-robot interaction through puzzle-solving and scenario-based learning focused on e-cigarette and tobacco hazards. Both groups will be assessed using validated questionnaires at three time points: baseline (pre-intervention), immediately post-intervention, and 1-month follow-up. Primary and secondary outcome measures will include changes in tobacco harm knowledge, health beliefs, smoking refusal self-efficacy, extended expectation confirmation, learning engagement, behavioral intention, and advocacy intention.

Who can participate

Age range

10 Years – 12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Fifth or sixth grade students from elementary schools in New Taipei City Age 10-12 years Written consent from parent/guardian Verbal assent from student Able to understand Chinese questionnaires Exclusion Criteria: * Prior participation in tobacco harm education trials History of tobacco-related allergies Unable to complete questionnaires Parental refusal to participate

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Tobacco Harm Knowledge

Timeframe: Baseline (pre-intervention), immediately post-intervention, and 1-month follow-up

Trial details

NCT IDNCT07501572

SponsorNational Taiwan Normal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-01

View on ClinicalTrials.gov More Tobacco Use trials